The Horse

DEC 2017

The Horse:Your Guide To Equine Health Care provides monthly equine health care information to horse owners, breeders, veterinarians, barn/farm managers, trainer/riding instructors, and others involved in the hands-on care of the horse.

Issue link: https://thehorse.epubxp.com/i/899161

Contents of this Issue

Navigation

Page 59 of 59

UNBRIDLE YOUR POTENTIAL RESTORING POTENTIAL Important Safety Information: PRASCEND is for use in horses only. Treatment with PRASCEND may cause loss of appetite. Most cases are mild. Weight loss, lack of energy and behavioral changes also may be observed. If severe, a temporary dose reduction may be necessary. PRASCEND has not been evaluated in breeding, pregnant or lactating horses, and may interfere with reproductive hormones in these horses. PRASCEND Tablets should not be crushed due to the potential for increased human exposure. Refer to package insert for complete product information. THE HORSE YOU KNOW IS STILL IN THERE. You and your horse have a unique connection, a bond like no other. But the clinical signs of PPID (pituitary pars intermedia dysfunction) can make a horse unrecognizable. Their energy, their vibrant coat, their overall spark can fade and disappear as the disease sets in and progresses. Here's the good news: The horse you know is still in there, hiding behind the signs of PPID. What's even better? Prascend ® (pergolide tablets), the fi rst and only FDA approved-treatment for PPID, can control the signs associated with PPID, and bring back the horse you know. Learn more at Prascend.com Prascend is a registered trademark of Boehringer Ingelheim Vetmedica, Inc. ©2017 Boehringer Ingelheim Vetmedica, Inc. EQU-0199-PRAS0717

Articles in this issue

Links on this page

Archives of this issue

view archives of The Horse - DEC 2017